The milestone moves what Oculis describes as the first genotype-guided registrational trial in DED a step closer to a readout ...
Carey said the take-home message is “if you have a patient who’s had MS and optic neuritis, and they call your office saying, ...
CHMP backs Accord Healthcare’s Lucentis biosimilar Fovlussea for nAMD, DMO, RVO and CNV ahead of an EC decision. Fovlussea enters a European market where ranibizumab biosimilars have been commercially ...
Prevent Blindness is observing its sixth annual Inflammatory Eye Disease (IED) Week from October 19 to 25, 2026, highlighting conjunctivitis and keratitis, thyroid eye disease (TED), and uveitis. 1 ...
Elizabeth A. Davis MD, FACS | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology ...
Keith Warren, MD | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, Modern ...
Steve Swalgen is national director of lab business, Santinelli International, Hauppauge, NY. Swalgen also is an advisory board member of the Optical Laboratory Association (OLA) and has developed and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results